ARCHIVES

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

This article is from The Cancer Letter archive.

Vol. 34 No. 32 | September 5, 2008

Download PDF Visit The Full Archive

Related Articles

DCPC Board Defers Decision On Hepatitis Vaccine Study, Rejects PAP Sensitivity Concepts

June 1, 1984

DCCP Board Approves Concept Of RFA, New, Competing Contracts

October 15, 1982

HHS: Gallo Committed Scientific Misconduct In AIDS Virus Discovery

January 8, 1993

Chemical Industry Sues NTP Over Listing PDC As Carcinogen; Environmental Groups Join Defense

June 23, 1989

Colon Cancer Screening Interval 5-10 Years Suggested

September 26, 2008

Extent Of Risk Reduction From Ovary Removal Varies According To BRCA Mutation

February 29, 2008